Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-031636
Filing Date
2024-07-10
Accepted
2024-07-10 19:53:47
Documents
1
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1720655620.html 4  
1 FORM 4 wk-form4_1720655620.xml 4 3629
  Complete submission text file 0001628280-24-031636.txt   5151
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3525 PIEDMONT RD., NE BUILDING 6, SUITE 700 ATLANTA GA 30305
Business Address
Barbarosh Craig A. (Reporting) CIK: 0001472457 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27446 | Film No.: 241110844